The Kroger Co. (KR) and The Kroger Family of Pharmacies announced that as part of its continued commitment to expanding access to high-demand GLP-1 therapies, Zepbound KwikPen, the newly launched, multi-dose delivery option of Eli Lilly’s (LLY) weight-management medication, is now available at participating Kroger pharmacies, bringing patients a more convenient option for obtaining their medication.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KR:
- Kroger price target raised to $83 from $81 at Evercore ISI
- Kroger price target raised to $71 from $68 at Citi
- Kroger Stock’s (KR) 18% Gain Proves That Groceries Are No Longer Boring
- Early notable gainers among liquid option names on March 6th
- Kroger price target raised to $82 from $80 at Telsey Advisory